デフォルト表紙
市場調査レポート
商品コード
1589833

体外式心室ドレーン市場:適応症別、エンドユーザー別-2025-2030年の世界予測

External Ventricular Drain Market by Indication (CSF Infection, Hydrocephalus, Intracranial Hypertension), End-User (Ambulatory Surgical Centers, Hospitals) - Global Forecast 2025-2030


出版日
発行
360iResearch
ページ情報
英文 185 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
体外式心室ドレーン市場:適応症別、エンドユーザー別-2025-2030年の世界予測
出版日: 2024年10月31日
発行: 360iResearch
ページ情報: 英文 185 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

体外式心室ドレーン市場は、2023年に57億8,000万米ドルと評価され、2024年には62億米ドルに達すると予測され、CAGR 7.39%で成長し、2030年には95億2,000万米ドルに達すると予測されています。

脳室外ドレーン(EVD)は、脳室から脳脊髄液(CSF)を外部の収集システムに排出することで、頭蓋内圧の上昇を管理するために使用される重要な医療機器です。EVDの必要性は、外傷性脳損傷、水頭症、頭蓋内出血などの治療における役割から生じています。EVDは集中治療や脳外科手術で主に使用され、三次医療機関における重要な応用範囲となっています。神経疾患の有病率の上昇、医療技術の進歩、ヘルスケア支出の増加などの影響を受け、EVDは着実に成長しています。医療インフラが拡大する新興市場は、主要企業にとって新たなビジネスチャンスとなります。しかし、感染リスク、機器関連の合併症、熟練した専門家の数の少なさなどの課題が、市場拡大の大きな制約となっています。さらに、規制当局の承認や厳格な医療コンプライアンス基準が、市場情勢に複雑さをもたらしています。技術革新のチャンスは、EVDの安全性と効率を高めることにあり、より良い患者モニタリングとデータ分析のためのスマートテクノロジーの統合がその可能性を持っています。さらに、生体適合素材や高度なドレナージシステムに関する調査も市場を前進させる可能性があります。企業は、専門知識やリソースを共有するための戦略的パートナーシップや共同事業に注力すべきです。医療従事者向けの継続的な教育・研修プログラムは、機器の取り扱いや患者の安全性に関する課題を軽減するために不可欠です。EVD市場は競争が激しく、絶え間ない技術革新が差別化のカギとなります。患者の安全性、製品の信頼性、使いやすさを優先する企業が成功を収める可能性が高いです。主要なオピニオン・リーダーと関わり、ヘルスケア・プロバイダーと強い関係を築くことは、満たされていないニーズを特定し、より良い臨床結果を得るために製品を調整する上で極めて重要です。

主な市場の統計
基準年[2023] 57億8,000万米ドル
予測年[2024] 62億米ドル
予測年[2030] 95億2,000万米ドル
CAGR(%) 7.39%

市場力学:急速に進化する体外式心室ドレーン市場の主要市場インサイトを公開

体外式心室ドレーン市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

  • 市場促進要因
    • 外傷および虚血性脳卒中の増加
    • 低侵襲の神経外科手術に対する需要の高まり
    • ヘルスケアインフラ強化のための投資増加
  • 市場抑制要因
    • 体外式心室ドレーン機器に関連する高コスト
  • 市場機会
    • 体外式心室ドレーン装置に関する調査活動の活発化
    • 脳室吻合術の設置の精度と効率を向上させる技術の進歩
  • 市場の課題
    • 脳室ドレナージ使用に伴う合併症

ポーターの5つの力:体外式心室ドレーン市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析:体外式心室ドレーン市場における外部からの影響の把握

外部マクロ環境要因は、体外式心室ドレーン市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析体外式心室ドレーン市場における競合情勢の把握

体外式心室ドレーン市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的な意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス体外式心室ドレーン市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、体外式心室ドレーン市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨体外式心室ドレーン市場における成功への道筋を描く

体外式心室ドレーン市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています:

1.市場の浸透度:現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度:新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化:最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報:競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション:将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています:

1.現在の市場規模と今後の成長予測は?

2.最高の投資機会を提供する製品、セグメント、地域はどこか?

3.市場を形成する主な技術動向と規制の影響とは?

4.主要ベンダーの市場シェアと競合ポジションは?

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 外傷や虚血性脳卒中の発生率の増加
      • 低侵襲性脳神経外科手術の需要の高まり
      • ヘルスケアインフラ強化への投資増加
    • 抑制要因
      • 体外式心室ドレーンデバイスに関連する高コスト
    • 機会
      • 体外式心室ドレーンデバイスでの調査活動の高度化
      • 脳室造設術の精度と効率を向上させる技術的進歩
    • 課題
      • 脳室ドレナージの使用に伴う合併症
  • 市場セグメンテーション分析
  • ポーターのファイブフォース分析
  • PESTEL分析
    • 政治的
    • 経済
    • 社交
    • 技術的
    • 法律上
    • 環境

第6章 体外式心室ドレーン市場適応症別

  • 脳脊髄液感染症
  • 水頭症
  • 頭蓋内圧亢進症
  • 脳室内出血
  • 髄膜炎

第7章 体外式心室ドレーン市場:エンドユーザー別

  • 外来手術センター
  • 病院

第8章 南北アメリカの体外式心室ドレーン市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第9章 アジア太平洋地域の体外式心室ドレーン市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第10章 欧州・中東・アフリカの体外式心室ドレーン市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第11章 競合情勢

  • 市場シェア分析2023
  • FPNVポジショニングマトリックス, 2023
  • 競合シナリオ分析
  • 戦略分析と提言

企業一覧

  • Argi Grup SaglIk Hiz. Tic. Ltd. Sti.
  • B. Braun Melsungen AG
  • Fuji Systems Co., Ltd.
  • Integra LifeSciences Corporation
  • IRRAS AB
  • Johnson & Johnson Services, Inc
  • KFF S. A.
  • Medtronic PLC
  • MOLLER Medical GmbH
  • Neuromedex GmbH
  • Sophysa SA
  • Spiegelberg GmbH & Co. KG
図表

LIST OF FIGURES

  • FIGURE 1. EXTERNAL VENTRICULAR DRAIN MARKET RESEARCH PROCESS
  • FIGURE 2. EXTERNAL VENTRICULAR DRAIN MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL EXTERNAL VENTRICULAR DRAIN MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EXTERNAL VENTRICULAR DRAIN MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. EXTERNAL VENTRICULAR DRAIN MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. EXTERNAL VENTRICULAR DRAIN MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL EXTERNAL VENTRICULAR DRAIN MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. EXTERNAL VENTRICULAR DRAIN MARKET DYNAMICS
  • TABLE 7. GLOBAL EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY CSF INFECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HYDROCEPHALUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INTRACRANIAL HYPERTENSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INTRAVENTRICULAR HEMORRHAGE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY MENINGITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 26. MEXICO EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 34. AUSTRALIA EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 36. CHINA EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 38. INDIA EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 40. INDONESIA EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 42. JAPAN EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 44. MALAYSIA EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 46. PHILIPPINES EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 48. SINGAPORE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 50. SOUTH KOREA EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 52. TAIWAN EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 54. THAILAND EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 56. VIETNAM EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 61. DENMARK EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 63. EGYPT EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 65. FINLAND EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 67. FRANCE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 69. GERMANY EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 71. ISRAEL EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 73. ITALY EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 75. NETHERLANDS EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 77. NIGERIA EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 79. NORWAY EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 81. POLAND EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 83. QATAR EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 85. RUSSIA EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SAUDI ARABIA EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH AFRICA EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 91. SPAIN EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 93. SWEDEN EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 95. SWITZERLAND EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 97. TURKEY EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED ARAB EMIRATES EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED KINGDOM EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. EXTERNAL VENTRICULAR DRAIN MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 103. EXTERNAL VENTRICULAR DRAIN MARKET, FPNV POSITIONING MATRIX, 2023
目次
Product Code: MRR-4103B31E0421

The External Ventricular Drain Market was valued at USD 5.78 billion in 2023, expected to reach USD 6.20 billion in 2024, and is projected to grow at a CAGR of 7.39%, to USD 9.52 billion by 2030.

External Ventricular Drains (EVDs) are critical medical devices used to manage elevated intracranial pressure by draining cerebrospinal fluid (CSF) from the ventricles of the brain to an external collection system. The necessity of EVDs arises from their role in treating conditions such as traumatic brain injury, hydrocephalus, and intracranial hemorrhage. These devices are predominantly used in intensive care settings and neurosurgical procedures, highlighting their critical application scope in tertiary healthcare institutions. Market insights reveal a steady growth trajectory for EVDs, influenced by the rising prevalence of neurological disorders, advancements in medical technology, and increased healthcare spending. Emerging markets with expanding healthcare infrastructure offer new opportunities for key players. However, challenges such as the risk of infection, device-related complications, and a limited number of skilled professionals pose significant limitations to market expansion. Furthermore, regulatory approvals and stringent healthcare compliance standards add layers of complexity to the market landscape. Opportunities for innovation lie in enhancing the safety and efficiency of EVDs, potentially through the integration of smart technology for better patient monitoring and data analytics. Moreover, research into biocompatible materials and advanced drainage systems could propel the market forward. Companies should focus on strategic partnerships and collaborative ventures to leverage shared expertise and resources. Continuing education and training programs for healthcare professionals are essential to mitigate challenges related to device handling and patient safety. The nature of the EVD market is highly competitive, with constant innovation being key to differentiation. Firms that prioritize patient safety, product reliability, and ease of use will likely find success. Engaging with key opinion leaders and fostering strong relationships with healthcare providers will be crucial in identifying unmet needs and tailoring products for better clinical outcomes.

KEY MARKET STATISTICS
Base Year [2023] USD 5.78 billion
Estimated Year [2024] USD 6.20 billion
Forecast Year [2030] USD 9.52 billion
CAGR (%) 7.39%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving External Ventricular Drain Market

The External Ventricular Drain Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing incidences of traumatic injuries and ischemic strokes
    • Growing demand for a minimally invasive neurosurgical procedure
    • Rising investment to enhance healthcare infrastructure
  • Market Restraints
    • High costs associated with external ventricular drain devices
  • Market Opportunities
    • Elevation on the research activities on external ventricular drain device
    • Technical advancements to improve the accuracy and efficiency of ventriculostomy placement
  • Market Challenges
    • Complications associated with the use of ventricular drainage

Porter's Five Forces: A Strategic Tool for Navigating the External Ventricular Drain Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the External Ventricular Drain Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the External Ventricular Drain Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the External Ventricular Drain Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the External Ventricular Drain Market

A detailed market share analysis in the External Ventricular Drain Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the External Ventricular Drain Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the External Ventricular Drain Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the External Ventricular Drain Market

A strategic analysis of the External Ventricular Drain Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the External Ventricular Drain Market, highlighting leading vendors and their innovative profiles. These include Argi Grup SaglIk Hiz. Tic. Ltd. Sti., B. Braun Melsungen AG, Fuji Systems Co., Ltd., Integra LifeSciences Corporation, IRRAS AB, Johnson & Johnson Services, Inc, KFF S. A., Medtronic PLC, MOLLER Medical GmbH, Neuromedex GmbH, Sophysa SA, and Spiegelberg GmbH & Co. KG.

Market Segmentation & Coverage

This research report categorizes the External Ventricular Drain Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Indication, market is studied across CSF Infection, Hydrocephalus, Intracranial Hypertension, Intraventricular Hemorrhage, and Meningitis.
  • Based on End-User, market is studied across Ambulatory Surgical Centers and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidences of traumatic injuries and ischemic strokes
      • 5.1.1.2. Growing demand for a minimally invasive neurosurgical procedure
      • 5.1.1.3. Rising investment to enhance healthcare infrastructure
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with external ventricular drain devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Elevation on the research activities on external ventricular drain device
      • 5.1.3.2. Technical advancements to improve the accuracy and efficiency of ventriculostomy placement
    • 5.1.4. Challenges
      • 5.1.4.1. Complications associated with the use of ventricular drainage
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. External Ventricular Drain Market, by Indication

  • 6.1. Introduction
  • 6.2. CSF Infection
  • 6.3. Hydrocephalus
  • 6.4. Intracranial Hypertension
  • 6.5. Intraventricular Hemorrhage
  • 6.6. Meningitis

7. External Ventricular Drain Market, by End-User

  • 7.1. Introduction
  • 7.2. Ambulatory Surgical Centers
  • 7.3. Hospitals

8. Americas External Ventricular Drain Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific External Ventricular Drain Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa External Ventricular Drain Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Argi Grup SaglIk Hiz. Tic. Ltd. Sti.
  • 2. B. Braun Melsungen AG
  • 3. Fuji Systems Co., Ltd.
  • 4. Integra LifeSciences Corporation
  • 5. IRRAS AB
  • 6. Johnson & Johnson Services, Inc
  • 7. KFF S. A.
  • 8. Medtronic PLC
  • 9. MOLLER Medical GmbH
  • 10. Neuromedex GmbH
  • 11. Sophysa SA
  • 12. Spiegelberg GmbH & Co. KG